Novavax Requests FDA Emergency Use Authorization for COVID-19 Vaccine
Novavax on Monday requested FDA emergency use authorization for its COVID-19 vaccine. The request was based partially on results from two large clinical trials of approximately 30,000 participants in the U.S. and Mexico that the company said demonstrated approximately 90 percent efficacy, The Hill reports. “We’re extremely proud of the work of our teams and […]
The post Novavax Requests FDA Emergency Use Authorization for COVID-19 Vaccine appeared first on Human Events…
Read More
0
